The aim of the present population-based cohort study was to analyze the association
between the prevalence of 32 types of human papilloma virus (HPV) in 615 female patients …

Background Reproductive well-being is a crucial element of women's health. Due to the
asymptomatic nature of gynaecological morbidities, women rarely seek medical advice in …

Two of the leading strategies to prevent cervical cancer are prophylactic human
papillomavirus (HPV) vaccination and routine Papanicolaou (Pap) testing. However …

Objective Female sex workers (FSWs) are at an increased risk of human immunodeficiency
virus (HIV) as well as human papillomavirus (HPV) infections and thus have an increased …

The primary objective of this research work is to develop a novel benchmark database of
digitized and calibrated, cervical cells obtained from slides of Papanicolaou smear test …

Background Potential care gaps in the cervical cancer screening process among women
diagnosed with cervical cancer in an era with increased human papillomavirus (HPV) testing …

Human papillomavirus (HPV) infection is a significant etiological factor and an important
prognosticator in cervical cancer. Indeed, researchers worldwide have confirmed these roles …

Background: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) cause infections
in the female genital tract, increasing susceptibility to and infectiousness of HIV. The …

In this open, extended follow-up study (NCT00929526, Clinicaltrials. gov), we evaluated the
human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine efficacy, immunogenicity and …

Cervical cancer is one of the most common causes of cancer-associated mortality in females
worldwide. Serum biomarkers are important tools for diagnosis, disease staging, monitoring …